Видео ютуба по тегу Hematologic Malignancy

CAR-T Cell Therapy in Hematologic Malignancies
CAR-T Cell Therapy in Hematologic Malignancies
CAR T Cells Impact the Treatment Landscape Across Hematologic Malignancies
CAR T Cells Impact the Treatment Landscape Across Hematologic Malignancies
HemePath Hub at CorePath: A Unique Learning Opportunity for Hematologic Cancers
HemePath Hub at CorePath: A Unique Learning Opportunity for Hematologic Cancers
Blood Review Series – Adolescent and Young Adult Malignant Hematology
Blood Review Series – Adolescent and Young Adult Malignant Hematology
Biomarkers of microbiota dysbiosis to predict treatment response in hematologic malignancies
Biomarkers of microbiota dysbiosis to predict treatment response in hematologic malignancies
Dr. Skarbnik on Combination Strategies of Immunotherapy in Hematologic Malignancies
Dr. Skarbnik on Combination Strategies of Immunotherapy in Hematologic Malignancies
Pre-Conference Perspectives on Hematologic Malignancies
Pre-Conference Perspectives on Hematologic Malignancies
Ig/TCR Testing in Hematologic Malignancies: From Clone Identification to Residual Disease Monitoring
Ig/TCR Testing in Hematologic Malignancies: From Clone Identification to Residual Disease Monitoring
Dr. Zelenetz invitation to the 17th International Congress on Hematologic Malignancies 2013
Dr. Zelenetz invitation to the 17th International Congress on Hematologic Malignancies 2013
Kidney Injury in hematologic malignancy, ESNT 2019 Prof Mohamed Sobh
Kidney Injury in hematologic malignancy, ESNT 2019 Prof Mohamed Sobh
Preventing and monitoring cardiotoxicities associated with treatment for hematologic malignancies
Preventing and monitoring cardiotoxicities associated with treatment for hematologic malignancies
Hematologic cancers
Hematologic cancers
CAR-T Integration Strategies Across Hematologic Cancers
CAR-T Integration Strategies Across Hematologic Cancers
COVID-19 in patients with hematologic malignancies
COVID-19 in patients with hematologic malignancies
Monoclonal Antibodies for Treatment in Hematologic Malignancies - Alison Moskowitz, MD
Monoclonal Antibodies for Treatment in Hematologic Malignancies - Alison Moskowitz, MD
CD123 targeted therapies for hematologic malignancies
CD123 targeted therapies for hematologic malignancies
Individualized Immunotherapy for Patients with solid and Hematologic Malignancies
Individualized Immunotherapy for Patients with solid and Hematologic Malignancies
Engaging the T-cell for the treatment of hematologic malignancies – Ralf Bargou
Engaging the T-cell for the treatment of hematologic malignancies – Ralf Bargou
III Individualized Immunotherapy for Patients with Solid and Hematologic Malignancies
III Individualized Immunotherapy for Patients with Solid and Hematologic Malignancies
AMP 2016 MRD Solutions for the Studies of Hematologic Malignancies – LymphoTrack® Assays
AMP 2016 MRD Solutions for the Studies of Hematologic Malignancies – LymphoTrack® Assays
U.C. Hematologic Malignancies Consortium
U.C. Hematologic Malignancies Consortium
Generation of Models of Human Hematologic Malignancies Using CRISPR Genome Engineering
Generation of Models of Human Hematologic Malignancies Using CRISPR Genome Engineering
COVID-19 & Hematologic Malignancies: Episode 4 - Effective Management & Patient Experience
COVID-19 & Hematologic Malignancies: Episode 4 - Effective Management & Patient Experience
Data-Driven Algorithms for Optimizing Laboratory Test Utilization for Hematologic Malignancies
Data-Driven Algorithms for Optimizing Laboratory Test Utilization for Hematologic Malignancies
How does COVID-19 affect patients with hematologic malignancies? ASH registry provides some answers
How does COVID-19 affect patients with hematologic malignancies? ASH registry provides some answers